Dong Baijun相关文献与解析，生知库 | 链接生命科学的每一步

Targeting the CCL5/CCR5 axis in tumor-stromal crosstalk to overcome cisplatin resistance in neuroendocrine prostate cancer

靶向肿瘤-基质相互作用中的CCL5/CCR5轴以克服神经内分泌前列腺癌的顺铂耐药性

期刊:Journal of Experimental & Clinical Cancer Research

Liu, Bo; Zhang, Weiwei; Ji, Yiyi; Wu, Jiajin; Su, Ruopeng; Liu, Xinyu; Li, Ang; Shen, Kai; Chai, Xinyu; Wu, Haotian; Ma, Zehua; Hu, Cong; Jiang, Zhou; Dong, Liang; Zhu, Yinjie; Dong, Baijun; Xue, Wei; Pan, Jiahua; Wang, Qi

Correction: PAX6 promotes neuroendocrine phenotypes of prostate cancer via enhancing MET/STAT5Amediated chromatin accessibility

更正：PAX6 通过增强 MET/STAT5A 介导的染色质可及性来促进前列腺癌的神经内分泌表型。

期刊:Journal of Experimental & Clinical Cancer Research

影响因子:12.8

doi:10.1186/s13046-024-03084-x

Jing, Nan; Du, Xinxing; Liang, Yu; Tao, ZhenKeke; Bao, Shijia; Xiao, Huixiang; Dong, Baijun; Gao, Wei-Qiang; Fang, Yu-Xiang

SERSomes for metabolic phenotyping and prostate cancer diagnosis

用于代谢表型分析和前列腺癌诊断的SERSomes

期刊:Cell Reports Medicine

影响因子:10.6

doi:10.1016/j.xcrm.2024.101579

Bi, Xinyuan; Wang, Jiayi; Xue, Bingsen; He, Chang; Liu, Fugang; Chen, Haoran; Lin, Linley Li; Dong, Baijun; Li, Butang; Jin, Cheng; Pan, Jiahua; Xue, Wei; Ye, Jian

Precise diagnosis and risk stratification of prostate cancer by comprehensive serum metabolic fingerprints: a prediction model study

利用血清代谢指纹图谱进行前列腺癌的精准诊断和风险分层：一项预测模型研究

期刊:International Journal of Surgery

影响因子:10.1

doi:10.1097/JS9.0000000000001033

Fei, Xiaochen; Du, Xinxing; Wang, Jiayi; Liu, Jiazhou; Gong, Yiming; Zhao, Zejun; Cao, Zhibin; Fu, Qibo; Zhu, Yinjie; Dong, Liang; Dong, Baijun; Pan, Jiahua; Sun, Wenshe; Xie, Shaowei; Xue, Wei

Prognostic value of [(18)F]FDG PET/CT in metastatic hormone-sensitive prostate cancer at initial diagnosis: a retrospective cohort study

[(18)F]FDG PET/CT在转移性激素敏感性前列腺癌初诊时的预后价值：一项回顾性队列研究

期刊:

影响因子:

doi:10.1080/07853890.2024.2411017

Li, Ang; Shen, Kai; Ji, Yiyi; Zhang, Weiwei; Liu, Bo; Su, Ruopeng; Zhou, Xiang; Dong, Liang; Zhu, Yinjie; Dong, Baijun; Pan, Jiahua; Wang, Qi; Xue, Wei

Engineering the MoS(2) /MXene Heterostructure for Precise and Noninvasive Diagnosis of Prostate Cancer with Clinical Specimens

利用 MoS(2)/MXene 异质结构对前列腺癌进行精确、无创的临床标本诊断

期刊:Advanced Science

影响因子:14.1

doi:10.1002/advs.202206494

Xie, Shaowei; Fei, Xiaochen; Wang, Jiayi; Zhu, Yi-Cheng; Liu, Jiazhou; Du, Xinxing; Liu, Xuesong; Dong, Liang; Zhu, Yinjie; Pan, Jiahua; Dong, Baijun; Sha, Jianjun; Luo, Yu; Sun, Wenshe; Xue, Wei

TRIM59 is suppressed by androgen receptor and acts to promote lineage plasticity and treatment-induced neuroendocrine differentiation in prostate cancer

TRIM59 受雄激素受体抑制，促进前列腺癌谱系可塑性和治疗诱导的神经内分泌分化

期刊:Oncogene

影响因子:6.9

doi:10.1038/s41388-022-02498-1

Liancheng Fan #, Yiming Gong #, Yuman He, Wei-Qiang Gao, Xuesen Dong, Baijun Dong, Helen He Zhu, Wei Xue

Early serial circulating tumor DNA sequencing predicts the efficacy of chemohormonal therapy in patients with metastatic hormone-sensitive prostate cancer

早期循环肿瘤DNA测序可预测转移性激素敏感性前列腺癌患者接受化疗联合激素治疗的疗效

期刊:Translational Oncology

影响因子:4.1

doi:10.1016/j.tranon.2023.101701

Du, Xinxing; Fei, Xiaochen; Wang, Jialin; Dong, Yanhao; Fan, Liancheng; Yang, Bin; Chen, Wei; Gong, Yiming; Xia, Binbin; Zhu, Hanjing; Wu, Fan; Wang, Yanqing; Dong, Liang; Zhu, Yinjie; Pan, Jiahua; Yao, Xudong; Dong, Baijun

Early Plasma Circulating Tumor DNA as a Potential Biomarker of Disease Recurrence in Non-metastatic Prostate Cancer

早期血浆循环肿瘤DNA作为非转移性前列腺癌疾病复发的潜在生物标志物

期刊:Cancer Research and Treatment

影响因子:3.8

doi:10.4143/crt.2022.1557

Fei, Xiaochen; Du, Xinxing; Gong, Yiming; Liu, Jiazhou; Fan, Liancheng; Wang, Jiayi; Wang, Yanqing; Zhu, Yinjie; Pan, Jiahua; Dong, Baijun; Xue, Wei

ATOH8 confers the vulnerability of tumor cells to ferroptosis by repressing SCD expression.

ATOH8 通过抑制 SCD 表达，使肿瘤细胞易受铁死亡的影响

Targeting the CCL5/CCR5 axis in tumor-stromal crosstalk to overcome cisplatin resistance in neuroendocrine prostate cancer

靶向肿瘤-基质相互作用中的CCL5/CCR5轴以克服神经内分泌前列腺癌的顺铂耐药性

Correction: PAX6 promotes neuroendocrine phenotypes of prostate cancer via enhancing MET/STAT5Amediated chromatin accessibility

更正：PAX6 通过增强 MET/STAT5A 介导的染色质可及性来促进前列腺癌的神经内分泌表型。

SERSomes for metabolic phenotyping and prostate cancer diagnosis

用于代谢表型分析和前列腺癌诊断的SERSomes

Precise diagnosis and risk stratification of prostate cancer by comprehensive serum metabolic fingerprints: a prediction model study

利用血清代谢指纹图谱进行前列腺癌的精准诊断和风险分层：一项预测模型研究

Prognostic value of [(18)F]FDG PET/CT in metastatic hormone-sensitive prostate cancer at initial diagnosis: a retrospective cohort study

[(18)F]FDG PET/CT在转移性激素敏感性前列腺癌初诊时的预后价值：一项回顾性队列研究

Engineering the MoS(2) /MXene Heterostructure for Precise and Noninvasive Diagnosis of Prostate Cancer with Clinical Specimens

利用 MoS(2)/MXene 异质结构对前列腺癌进行精确、无创的临床标本诊断

TRIM59 is suppressed by androgen receptor and acts to promote lineage plasticity and treatment-induced neuroendocrine differentiation in prostate cancer

TRIM59 受雄激素受体抑制，促进前列腺癌谱系可塑性和治疗诱导的神经内分泌分化

Early serial circulating tumor DNA sequencing predicts the efficacy of chemohormonal therapy in patients with metastatic hormone-sensitive prostate cancer

早期循环肿瘤DNA测序可预测转移性激素敏感性前列腺癌患者接受化疗联合激素治疗的疗效

Early Plasma Circulating Tumor DNA as a Potential Biomarker of Disease Recurrence in Non-metastatic Prostate Cancer

早期血浆循环肿瘤DNA作为非转移性前列腺癌疾病复发的潜在生物标志物